Chandler-based Insys Therapeutics filed for Chapter 11 bankruptcy protection, following a $225 million settlement agreement with the federal government over a criminal and civil investigation into the shady marketing practices to sell its highly addictive fentanyl spray, Subsys.
Due to the declared bankruptcy, Insys will be...
